Dialybrid Foundation

LIFTT, the investment operating company founded by Fondazione Compagnia Di San Paolo and Politecnico di Torino, and Bioengineering Laboratories S.r.l. (“BEL”), a medical device company controlled by the Delta Med group and its founder Francesco Greco, join in a strategic-financialpartnership in the BioMed sector.

https://www.liftt.com/wp-content/uploads/2020/08/LIFTT_focuses_on_Dialybrid_a_new_frontier_in_haemodialysis.pdf